FDA panel votes for full approval of Pfizer’s covid pill Paxlovid
The FDA’s advisory panel recommended full approval of Pfizer’s Covid antiviral treatment Paxlovid for high-risk adults.
Drugs
Health
Pharma
83.3% ACS patients achieve normality: Lupin Digital Health study
Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs.
Drugs
Medical
Pharma
Glenmark gets FDA nod for trials in US on tumour, cancer patients
Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in.
Drugs
Medical
Pharma
Merck says trial hypertension drug enhances patients’ walk time
Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.
Drugs
Pharma
FDA rejects Cytokinetics heart disease trial drug
Cytokinetics, a US-based biopharmaceutical company, announced the FDA had rejected its new drug application for approving a trial drug to treat heart problems.
Drugs
Pharma
FDA nod for Granules India’s drug to treat high blood pressure
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets.
Drugs
Pharma
FDA closes inspection of Strides Pharma’s Bangalore unit
The USFDA has closed an inspection of India’s Strides Pharma Science in southern Bangalore, which serves markets in the US, Europe and Australia,.
Drugs
Pharma
Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.
Drugs
Medical
Pharma
Merck’s pill fails to prevent COVID-19 infection among households
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Drugs
Pharma
Zydus gets FDA green light for drugs to treat diabetes, shingles
Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other.